Insider Transactions in Q1 2022 at Vaxcyte, Inc. (PCVX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2022
|
Paul Sauer SVP Process Dev, Manufacturing |
SELL
Open market or private sale
|
Direct |
3,000
-9.64%
|
$75,000
$25.0 P/Share
|
|
Mar 22
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,712
-1.08%
|
$185,088
$24.62 P/Share
|
|
Mar 22
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,712
+1.07%
|
$7,712
$1.79 P/Share
|
|
Mar 21
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
14,288
-1.0%
|
$357,200
$25.3 P/Share
|
|
Mar 21
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
14,288
+1.95%
|
$14,288
$1.79 P/Share
|
|
Mar 18
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
3,100
-7.09%
|
$80,600
$26.13 P/Share
|
|
Mar 18
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,100
+6.62%
|
$15,500
$5.35 P/Share
|
|
Mar 11
2022
|
Jeff Fairman VP, Research |
SELL
Open market or private sale
|
Indirect |
10,000
-2.93%
|
$250,000
$25.5 P/Share
|
|
Mar 10
2022
|
Paul Sauer SVP Process Dev, Manufacturing |
SELL
Open market or private sale
|
Direct |
6,000
-16.16%
|
$150,000
$25.0 P/Share
|
|
Mar 02
2022
|
Grant Pickering CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
71,875
+9.27%
|
-
|
|
Mar 02
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Grant, award, or other acquisition
|
Direct |
37,500
+48.0%
|
-
|
|
Mar 02
2022
|
Paul Sauer SVP Process Dev, Manufacturing |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+21.22%
|
-
|
|
Mar 02
2022
|
Harpreet S. Dhaliwal SVP Cml Mfg & Supply Chain |
BUY
Grant, award, or other acquisition
|
Direct |
17,500
+50.0%
|
-
|
|
Mar 02
2022
|
Jeff Fairman VP, Research |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+26.51%
|
-
|
|
Mar 02
2022
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+36.8%
|
-
|
|
Mar 01
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
SELL
Open market or private sale
|
Direct |
6,200
-66.49%
|
$148,800
$24.0 P/Share
|
|
Mar 01
2022
|
Andrew Guggenhime PRESIDENT AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,200
+39.94%
|
$31,000
$5.35 P/Share
|
|
Feb 24
2022
|
Jim Wassil CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
10,000
-35.79%
|
$220,000
$22.0 P/Share
|
|
Feb 24
2022
|
Jim Wassil CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+26.35%
|
$20,000
$2.42 P/Share
|